Actively Recruiting
Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
Led by Sanofi · Updated on 2026-04-14
500
Participants Needed
22
Research Sites
237 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The OBS19236 is a retrospective and prospective, non-interventional observational study in COPD patients treated with dupilumab as part of routine clinical care. It will follow-up about 350 to 500 participants over 36 months in up to 50 sites in France.
CONDITIONS
Official Title
Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients willing and able to sign informed consent for use of their pseudonymized clinical data.
- Adults aged 18 years and older.
- Patients with uncontrolled Chronic Obstructive Pulmonary Disease (COPD) despite LAMA/LABA/ICS therapy (or LAMA/LABA if ICS not appropriate).
- Blood eosinophil count of 300 cells/microL or higher.
- Patients newly starting dupilumab treatment for COPD as prescribed by their doctor.
You will not qualify if you...
- Patients not eligible for dupilumab treatment according to its summary of product characteristics.
- Participation in an interventional study currently or within 12 months before enrollment that may affect study assessments.
- Any acute or chronic condition that limits the ability to complete questionnaires, participate in the study, or affects interpretation of results according to the treating physician.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 22 locations
1
Investigational Site Number : 2500021
Aix-en-Provence, France, 13616
Actively Recruiting
2
Investigational Site Number : 2500043
Blois, France, 41016
Actively Recruiting
3
Investigational Site Number : 2500044
Brest, France, 29200
Actively Recruiting
4
Investigational Site Number : 2500009
Colmar, France, 68024
Actively Recruiting
5
Investigational Site Number : 2500031
Contamine-sur-Arve, France, 74130
Actively Recruiting
6
Investigational Site Number : 2500022
Juan-les-Pins, France, 06600
Actively Recruiting
7
Investigational Site Number : 2500020
Le Chesnay, France, 78157
Actively Recruiting
8
Investigational Site Number : 2500038
Libourne, France, 33500
Actively Recruiting
9
Investigational Site Number : 2500033
Lyon, France, 69008
Actively Recruiting
10
Investigational Site Number : 2500024
Marseille, France, 13003
Actively Recruiting
11
Investigational Site Number : 2500002
Montpellier, France, 34090
Actively Recruiting
12
Investigational Site Number : 2500047
Morlaix, France, 29600
Actively Recruiting
13
Investigational Site Number : 2500040
Niort, France, 79021
Actively Recruiting
14
Investigational Site Number : 2500026
Nîmes, France, 30029
Actively Recruiting
15
Investigational Site Number : 2500017
Paris, France, 400026
Actively Recruiting
16
Investigational Site Number : 2500001
Pessac, France, 33604
Actively Recruiting
17
Investigational Site Number : 2500034
Pierre-Bénite, France, 69495
Actively Recruiting
18
Investigational Site Number : 2500048
Saint-Pierre, France, 97448
Actively Recruiting
19
Investigational Site Number : 2500028
Toulouse, France, 31059
Actively Recruiting
20
Investigational Site Number : 2500029
Toulouse, France, 31076
Actively Recruiting
21
Investigational Site Number : 2500010
Vantoux, France, 57070
Actively Recruiting
22
Investigational Site Number : 2500035
Villeurbanne, France, 69100
Actively Recruiting
Research Team
T
Trial Transparency email recommended (Toll free for US & Canada)
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here